Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Jun 21, 2023
Date Accepted: Feb 19, 2024

The final, peer-reviewed published version of this preprint can be found here:

Barriers to COVID-19 Vaccination in a Troop of Fleet Antiterrorism Security Team Marines: Observational Study

Blazek ES, Bucher A

Barriers to COVID-19 Vaccination in a Troop of Fleet Antiterrorism Security Team Marines: Observational Study

JMIR Form Res 2024;8:e50181

DOI: 10.2196/50181

PMID: 38502179

PMCID: 10988372

Barriers to COVID-19 Vaccination in a Troop of FAST Marines: Notes from the Field

  • E. Susanne Blazek; 
  • Amy Bucher

ABSTRACT

Background:

In 2019, the World Health Organization declared the reluctance to vaccinate despite the availability of vaccination services as one of the top 10 threats to global health. Since the novel coronavirus (COVID-19) emerged in late 2019, COVID-19 vaccination specifically has been deemed a critical public health priority. In early 2021, self-reported reluctance to vaccinate among military personnel might have been considered a significant threat to national security. Unlike the flu, TDAP, smallpox, and other vaccines, which are routine and a required aspect of force readiness, the newly developed COVID-19 vaccine was initially optional to members of the US military, before becoming mandatory for a period, and finally being declared optional again on January 10, 2023. Having a choice architecture that makes COVID-19 vaccination optional, rather than required, for military personnel could inadvertently undermine military readiness if vaccination uptake does not reach an acceptable threshold.

Objective:

The purpose of this observational study was to examine Marines’ self-reported reasons for planning to decline the COVID-19 vaccine to understand their barriers to vaccination.

Methods:

As the vaccination became available to one company of Fleet Antiterrorism Security Team (FAST) Marines in early 2021, company command required those planning to decline vaccination to write an essay with up to five reasons for their choice. These essays provide the data for this study. Qualitative descriptive analysis was used to thematically categorize FAST Marines’ written reasons for planning to decline the COVID-19 vaccine into a codebook. Interrater agreement was very good (κ = 0.81).

Results:

A troop of 47 Marines provided 235 reasons why they planned to decline the COVID-19 vaccine. Most frequent reasons were difficulty understanding health information (45%), low estimates of risk (14%), and fear of physical discomfort (12%). Resulting interventions directly targeted Marines’ self-reported reasons by reducing barriers (e.g., normalized getting the vaccine), increasing vaccine benefits (e.g., improved access to base gyms and recreational facilities), and increasing non-vaccine friction (e.g., required in writing five reasons for declining the vaccine).

Conclusions:

Understanding the barriers military personnel experience toward COVID-19 vaccination remains critical despite the success of COVID-19 vaccination experienced to date. Insights from subpopulations like FAST Marines can enhance our ability to identify appropriate barriers and intervention techniques to influence COVID-19 vaccination behaviors.


 Citation

Please cite as:

Blazek ES, Bucher A

Barriers to COVID-19 Vaccination in a Troop of Fleet Antiterrorism Security Team Marines: Observational Study

JMIR Form Res 2024;8:e50181

DOI: 10.2196/50181

PMID: 38502179

PMCID: 10988372

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.